6.3 Isolation, Culture, and Identification of Viruses

Historical Context and Virus Cultivation

Historical context of filterable agents

In the late 1800s, researchers discovered that some infectious agents could pass through porcelain filters designed to trap bacteria. This finding upended the assumption that all pathogens were cellular organisms like bacteria or protozoa.

• Dmitri Ivanovsky (1892) and Martinus Beijerinck (1898) showed that the agent causing tobacco mosaic disease was smaller than any known bacterium. Beijerinck called it a contagium vivum fluidum ("living contagious fluid"), and the pathogen was later named tobacco mosaic virus (TMV).
• These experiments launched virology as its own discipline. Researchers began studying how viruses differ from bacteria, particularly the fact that viruses require living host cells to replicate. That requirement drove early work on virus-host interactions: how viruses enter cells, hijack replication machinery, assemble new particles, and release them.

Steps in virus cultivation

1. Specimen collection and handling

   • Collect clinical specimens based on the suspected infection site: nasopharyngeal swabs, blood, urine, stool, or tissue biopsies.
   • Transport specimens to the lab promptly using viral transport media (VTM), which prevents desiccation and maintains proper pH.
   • Keep specimens cold: 4°C for short-term processing, or -70°C for longer storage. Temperature matters because many enveloped viruses lose infectivity quickly at room temperature.

2. Virus isolation and cultivation

   • Inoculate specimens onto a suitable host system: cell cultures, embryonated eggs, or laboratory animals (mice, guinea pigs).
   • Monitor for signs of viral infection. In cell cultures, look for cytopathic effects (CPE), which are visible changes in cell morphology such as rounding, syncytia formation, or cell lysis. In animals, monitor for disease symptoms.
   • Confirm the presence of virus with diagnostic tests like immunofluorescence assays or PCR.
   • Determine the viral titer to quantify how much infectious virus is in the sample (more on quantification below).

3. Virus identification and characterization

   • Serological tests identify the virus based on its antigenic properties. Examples include neutralization assays (where antibodies block viral infectivity) and ELISA (enzyme-linked immunosorbent assay).
   • Molecular tests detect and characterize the virus at the genetic level. PCR amplifies specific viral nucleic acid sequences, and genome sequencing can identify the exact strain or variant.
   • Electron microscopy reveals virus morphology: capsid symmetry (icosahedral vs. helical), presence or absence of an envelope, and particle size.

Virus Cultivation Methods

In vivo vs. in vitro cultivation methods

In vivo methods

Viruses are grown in laboratory animals (mice, ferrets) or embryonated chicken eggs. Embryonated eggs are still widely used for influenza vaccine production.

• Advantages:
  • Provide a more natural environment for replication, which allows researchers to study pathogenesis and immune responses.
  • Useful for viruses that grow poorly in cell culture (e.g., some hepatitis viruses).
• Limitations:
  • Ethical concerns with animal use.
  • Higher cost and longer turnaround time.
  • Viruses can adapt to the animal host and acquire mutations that change their properties, which may not reflect human infection accurately.

In vitro methods

Viruses are grown in cell cultures derived from animal or human tissues. Three main types exist: primary cell cultures (freshly isolated from tissue, limited lifespan), continuous (immortalized) cell lines (e.g., HeLa, Vero cells; can be passaged indefinitely), and organ cultures (maintain tissue architecture).

• Advantages:
  • More controlled and standardized than animal models.
  • Allow detailed study of virus-cell interactions at the molecular level.
  • Generally cheaper and faster.
  • Enable quantitative assays like plaque assays and focus-forming assays.
• Limitations:
  • Not all viruses grow in cell culture. Norovirus, for example, was historically very difficult to cultivate in vitro.
  • Cell cultures don't fully replicate the complexity of a whole organism (no immune system, no tissue-level architecture).
  • Risk of contamination by bacteria, fungi, or mycoplasma, which can produce misleading results.

Virus Isolation and Quantification

Once a virus is cultivated, you need ways to measure and purify it.

• Virus isolation separates a specific virus from a complex clinical sample. Typically this involves serial passage in cell culture until a pure viral population is obtained.
• Viral load measurement determines the amount of virus in a patient's body fluids (often reported as copies/mL via quantitative PCR). This is critical for monitoring disease progression and treatment response, as in HIV or hepatitis C management.
• Virus purification produces highly concentrated, clean viral preparations. Techniques include ultracentrifugation (often with density gradients like cesium chloride or sucrose) and chromatography. Pure preparations are essential for vaccine production and structural studies.
• Viral vectors are engineered viruses stripped of their disease-causing genes and loaded with therapeutic genetic material. They're key tools in gene therapy (e.g., adeno-associated virus vectors) and in some vaccine platforms (e.g., adenovirus-vectored COVID-19 vaccines).